Shareholding disclosure

Benoit Villers, Pully Marc Cattelani, Genolier

Declared position

7.97%

Threshold

Crossed upwards

Timeline

Published

12.04.2019

Transaction

08.04.2019

Voting rights breakdown

Voting rights acquired7.97%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ4A00013

Beneficial owner

Benoit Villers, Pully Marc Cattelani, Genolier

Declared address

Benoit Villers, Pully Marc Cattelani, Genolier

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Benoit Villers, Pully Marc Cattelani, Genolier

Kuros Biosciences AG12.04.2019TAJ4A00013

Disclosure summary

Benoit Villers, Pully Marc Cattelani, Genolier disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 12.04.2019, at 7.97% of voting rights. Notice category: Single shareholder.

Disclosed position

7.97%

Voting rights acquired

Voting rights acquired7.97%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Benoit Villers, Pully Marc Cattelani, Genolier disclosed a holding in Kuros Biosciences AG, published on 12.04.2019.

Publication date12.04.2019

Transaction date08.04.2019

Issuing companyKuros Biosciences AG

Beneficial ownerBenoit Villers, Pully Marc Cattelani, Genolier

Declared addressBenoit Villers, Pully Marc Cattelani, Genolier

CategorySingle shareholder

Voting rights acquired7.97%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAJ4A00013

Source: SIX Exchange Regulation · Publication date: 12.04.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open